あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/07/24 | 1,495 | 1,495 | 1,471 | 1,482 | -2 | -0.1% | 63,500 |
| 2023/07/21 | 1,485 | 1,490 | 1,477 | 1,484 | +12 | +0.8% | 43,000 |
| 2023/07/20 | 1,471 | 1,489 | 1,466 | 1,472 | ±0 | ±0% | 55,300 |
| 2023/07/19 | 1,453 | 1,472 | 1,447 | 1,472 | +27 | +1.9% | 62,200 |
| 2023/07/18 | 1,445 | 1,457 | 1,442 | 1,445 | ±0 | ±0% | 35,800 |
| 2023/07/14 | 1,454 | 1,458 | 1,435 | 1,445 | -4 | -0.3% | 56,200 |
| 2023/07/13 | 1,435 | 1,453 | 1,435 | 1,449 | +27 | +1.9% | 59,200 |
| 2023/07/12 | 1,444 | 1,453 | 1,422 | 1,422 | -11 | -0.8% | 79,400 |
| 2023/07/11 | 1,435 | 1,442 | 1,422 | 1,433 | ±0 | ±0% | 108,600 |
| 2023/07/10 | 1,430 | 1,443 | 1,420 | 1,433 | +16 | +1.1% | 114,100 |
| 2023/07/07 | 1,413 | 1,427 | 1,403 | 1,417 | +3 | +0.2% | 99,800 |
| 2023/07/06 | 1,446 | 1,446 | 1,396 | 1,414 | -34 | -2.3% | 115,400 |
| 2023/07/05 | 1,424 | 1,452 | 1,418 | 1,448 | +29 | +2% | 92,900 |
| 2023/07/04 | 1,422 | 1,429 | 1,418 | 1,419 | -24 | -1.7% | 79,700 |
| 2023/07/03 | 1,450 | 1,457 | 1,439 | 1,443 | +2 | +0.1% | 58,200 |
| 2023/06/30 | 1,450 | 1,458 | 1,436 | 1,441 | -5 | -0.3% | 92,000 |
| 2023/06/29 | 1,450 | 1,459 | 1,440 | 1,446 | +4 | +0.3% | 117,400 |
| 2023/06/28 | 1,427 | 1,444 | 1,415 | 1,442 | +25 | +1.8% | 77,300 |
| 2023/06/27 | 1,455 | 1,455 | 1,400 | 1,417 | +17 | +1.2% | 117,800 |
| 2023/06/26 | 1,417 | 1,418 | 1,380 | 1,400 | -17 | -1.2% | 50,600 |
| 2023/06/23 | 1,435 | 1,439 | 1,407 | 1,417 | +10 | +0.7% | 112,600 |
| 2023/06/22 | 1,390 | 1,417 | 1,388 | 1,407 | +22 | +1.6% | 80,900 |
| 2023/06/21 | 1,380 | 1,400 | 1,375 | 1,385 | +17 | +1.2% | 191,900 |
| 2023/06/20 | 1,366 | 1,371 | 1,360 | 1,368 | +2 | +0.1% | 47,600 |
| 2023/06/19 | 1,362 | 1,370 | 1,353 | 1,366 | +23 | +1.7% | 89,900 |
| 2023/06/16 | 1,329 | 1,363 | 1,329 | 1,343 | +35 | +2.7% | 242,300 |
| 2023/06/15 | 1,304 | 1,327 | 1,300 | 1,308 | +11 | +0.8% | 117,800 |
| 2023/06/14 | 1,300 | 1,305 | 1,289 | 1,297 | +9 | +0.7% | 110,100 |
| 2023/06/13 | 1,280 | 1,293 | 1,280 | 1,288 | +16 | +1.3% | 86,900 |
| 2023/06/12 | 1,256 | 1,277 | 1,256 | 1,272 | +20 | +1.6% | 53,000 |
| 2023/06/09 | 1,255 | 1,255 | 1,225 | 1,252 | +25 | +2% | 58,400 |
| 2023/06/08 | 1,256 | 1,257 | 1,220 | 1,227 | -15 | -1.2% | 70,300 |
| 2023/06/07 | 1,255 | 1,268 | 1,242 | 1,242 | +8 | +0.6% | 77,800 |
| 2023/06/06 | 1,231 | 1,234 | 1,214 | 1,234 | -14 | -1.1% | 99,900 |
| 2023/06/05 | 1,254 | 1,260 | 1,247 | 1,248 | +10 | +0.8% | 41,000 |
| 2023/06/02 | 1,217 | 1,244 | 1,217 | 1,238 | +20 | +1.6% | 31,600 |
| 2023/06/01 | 1,211 | 1,241 | 1,210 | 1,218 | +6 | +0.5% | 43,600 |
| 2023/05/31 | 1,240 | 1,240 | 1,211 | 1,212 | -37 | -3% | 76,400 |
| 2023/05/30 | 1,250 | 1,266 | 1,233 | 1,249 | -17 | -1.3% | 34,400 |
| 2023/05/29 | 1,262 | 1,276 | 1,250 | 1,266 | +25 | +2% | 49,400 |
| 2023/05/26 | 1,258 | 1,267 | 1,239 | 1,241 | -32 | -2.5% | 38,600 |
| 2023/05/25 | 1,263 | 1,283 | 1,263 | 1,273 | +2 | +0.2% | 33,800 |
| 2023/05/24 | 1,270 | 1,285 | 1,266 | 1,271 | -6 | -0.5% | 26,800 |
| 2023/05/23 | 1,290 | 1,294 | 1,264 | 1,277 | -13 | -1% | 50,000 |
| 2023/05/22 | 1,263 | 1,290 | 1,258 | 1,290 | +27 | +2.1% | 38,900 |
| 2023/05/19 | 1,241 | 1,267 | 1,241 | 1,263 | +11 | +0.9% | 96,700 |
| 2023/05/18 | 1,260 | 1,260 | 1,235 | 1,252 | -14 | -1.1% | 57,800 |
| 2023/05/17 | 1,279 | 1,279 | 1,255 | 1,266 | -13 | -1% | 49,900 |
| 2023/05/16 | 1,280 | 1,281 | 1,256 | 1,279 | +3 | +0.2% | 39,300 |
| 2023/05/15 | 1,250 | 1,278 | 1,250 | 1,276 | +35 | +2.8% | 67,500 |
201～
250
件表示中 / 766件
類似銘柄と比較する
現在ご覧いただいている「あすかＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかＨＤ | 228,400円 | +0.3% | +2.7% | 2.19% | 12.94倍 | 1.04倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| 栄研化 | 214,600円 | +7.6% | +57.5% | 2.47% | 16.57倍 | 1.63倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割弱。尿検査（ウロ）、遺伝子検査も育成 |
| ＪＣＲファーマ | 63,600円 | -3.7% | -36.7% | 3.14% | 21.45倍 | 1.43倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| 生化学 | 78,400円 | +10.5% | +169.1% | 3.83% | 12.40倍 | 0.59倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| 富士製薬 | 151,800円 | +12.7% | +1.8% | 2.80% | 5.97倍 | 0.84倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
市場注目の銘柄
チャート関連のコラム
